OnKure Therapeutics OKUR
NASDAQ OKUR
$2.52 -0.06 (-2.33%)
At close: Oct 23, 2026 · 4:00 PM EDT

OnKure Therapeutics (OKUR) Cash & Current Investments (2020 - 2026)

Updated

OnKure Therapeutics (OKUR) recorded Cash & Current Investments of $176.39 million in Q2 2026, up 111.5% from $83.4 million a year earlier but down 8.2% from the prior quarter.

Analysis

OnKure Therapeutics (OKUR) Cash & Current Investments (2020 - 2026) Analysis & Trends

At the end of FY2025, OnKure Therapeutics reported Cash & Current Investments of $59.1 million, down 46.7% from FY2024.

  • Annual Cash & Current Investments has a five-year compound annual growth rate of 2.0% (FY2020 to FY2025).
  • Across earlier years, Cash & Current Investments came in at $110.8 million in FY2024 (+5.3%), $105.23 million in FY2023 (+4.0%), $101.17 million in FY2022 (-31.5%) and $147.67 million in FY2021 (+175.4%).
  • Quarterly Cash & Current Investments has ranged from $59.1 million in Q4 2025 to $192.11 million in Q1 2026 over the past five years.
  • On a year-over-year basis, Cash & Current Investments rose in five of the last eight quarters, with growth averaging 18.4%.
  • Peak year-over-year performance for Cash & Current Investments in the last five years was growth of 175.4% in Q4 2021, against a decline of 46.7% in Q4 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $192.11 million (Q1 2026), $59.1 million (Q4 2025) and $70.33 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 17.23 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 6.57 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 11.70 Bn
10 OnKure Therapeutics 102.05 Mn -395.87 Mn - 176.39 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 176.39 Mn
Mar 31, 2026 192.11 Mn
Dec 31, 2025 59.10 Mn
Sep 30, 2025 70.33 Mn
Jun 30, 2025 83.40 Mn
Mar 31, 2025 96.70 Mn
Dec 31, 2024 110.80 Mn
Sep 30, 2024 76.70 Mn
Jun 30, 2024 76.67 Mn
Mar 31, 2024 82.84 Mn
Dec 31, 2023 105.23 Mn
Sep 30, 2023 125.61 Mn
Jun 30, 2023 142.68 Mn
Mar 31, 2023 93.79 Mn
Dec 31, 2022 101.17 Mn
Sep 30, 2022 116.08 Mn
Jun 30, 2022 126.85 Mn
Mar 31, 2022 138.66 Mn
Dec 31, 2021 147.67 Mn
Sep 30, 2021 157.73 Mn
API Access

OnKure Therapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=OKUR&period=max&api_key=YOUR_API_KEY